Thomas Kurt Eigentler (Thomas K Eigentler, T Eigentler, Thomas Eigentler)

Loop profile ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 24

Top Venues

Cancers

Journal for immunotherapy of cancer

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Felix Peisen, Annika Gerken, Alessa Hering, Isabel Dahm, Konstantin Nikolaou, Sergios Gatidis, Thomas Kurt Eigentler, Teresa Amaral, Jan H Moltz, Ahmed E Othman
Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? Cancers 16 (15) (2024)
Felix Peisen, Annika Gerken, Alessa Hering, Isabel Dahm, Konstantin Nikolaou, Sergios Gatidis, Thomas Kurt Eigentler, Teresa Amaral, Jan H Moltz, Ahmed E Othman
Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? Cancers 16 (15) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hauschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas Kurt Eigentler, Victoria Casado Echarren, Brian Stein, Marie Beylot-Barry, Sophie Dalac, Brigitte Dréno, Michael R Migden, Axel Hausschild, Chrysalyne D Schmults, Annette M Lim, Suk-Young Yoo, Anne J Paccaly, Apostolos Papachristos, Jenny-Hoa Nguyen, Emmanuel Okoye, Frank Seebach, Jocelyn Booth, Israel Lowy, Matthew G Fury, Alexander D Guminski
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. Journal for immunotherapy of cancer 12 (3) (2024)
Valentin Aebischer, Amar Abu-Ghazaleh, Gisela Metzler, Lena Riedl, Claus Garbe, Lukas Flatz, Thomas Kurt Eigentler, Stephan Forchhammer
Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stage. Pigment cell & melanoma research (2023)
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, Thomas Kurt Eigentler, Friedegund Meier, Peter Mohr, Tobias Pukrop, Alexander Roesch, Dirk Vordermark, Christina Wendl, Ralf Gutzmer
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 15 (13) (2023)
Stephan Forchhammer, Amar Abu-Ghazaleh, Gisela Metzler, Claus Garbe, Thomas Kurt Eigentler
Development of an Image Analysis-Based Prognosis Score Using Google's Teachable Machine in Melanoma. Cancers 14 (9) (2022)
Annette Pflugfelder, Xuan Ling Hilary Yong, Kasturee Jagirdar, Thomas Kurt Eigentler, H Peter Soyer, Richard A Sturm, Lukas Flatz, David L Duffy
Genome-Wide Association Study Suggests the Variant rs7551288*A within the DHCR24 Gene Is Associated with Poor Overall Survival in Melanoma Patients. Cancers 14 (10) (2022)
Felix Peisen, Annika Hänsch, Alessa Hering, Andreas Stefan Brendlin, Saif Afat, Konstantin Nikolaou, Sergios Gatidis, Thomas Kurt Eigentler, Teresa Amaral, Jan H Moltz, Ahmed E Othman
Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy. Cancers 14 (12) (2022)
Andrea Forschner, Heike Niessner, Tobias Sinnberg, Thomas Kurt Eigentler, Teresa Amaral, Ferdinand Seith, Claus Garbe, Saskia Biskup, Florian Battke
Zirkulierende Tumor-DNA (ctDNA) bei der Entdeckung von Rezidiven bei Melanompatienten mit adjuvanter Anti-PD-1-Therapie. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20 (6) (2022)
Henner Stege, Sara Schneider, Andrea Forschner, Thomas Kurt Eigentler, Dorothée Nashan, Svea Huening, Frank Meiss, Saskia Lehr, Martin Kaatz, Robert Kuchen, Katharina C Kaehler, Maximilian Haist, Jutta Huebner, Carmen Loquai
eHealth Literacy in German Skin Cancer Patients. International journal of environmental research and public health 19 (14) (2022)
Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Kurt Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7) (2022)
Thomas Kurt Eigentler
Benefits of a nationwide population-based skin cancer screening programme - still a controversial debate. The British journal of dermatology (2021)
Lina María Serna Higuita, Teresa Amaral, Andrea Forschner, Ulrike Leiter, Lukas Flatz, Olivia Seeber, Ioannis Thomas, Claus Garbe, Thomas Kurt Eigentler, Peter Martus
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry. Cancers 13 (23) (2021)
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, Andrea Forschner, Christine Fink, Iris Spänkuch, Ioanna Tampouri, Thomas Kurt Eigentler, Benjamin Weide, Holger A Haenssle, Claus Garbe
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknesses. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 18 (7) (2020)
Maria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, Markus Kowarik, Andreas Meiwes, Thomas Kurt Eigentler, Alisa Müller, Claus Garbe, Ulf Ziemann, Ghazaleh Tabatabai, Andrea Forschner
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 18 (2) (2019)
Lukas Kofler, Christoph Berg, Katrin Kofler, Andrea Geipel, Hans-Peter Lipp, Alisa Müller, Thomas Kurt Eigentler, Andrea Forschner
Simultaneous targeted therapy for metastatic melanoma and hepatitis C. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 18 (1) (2019)
Helmut Breuninger, Thomas Kurt Eigentler, Hans-Martin Häfner, Ulrike Leiter
Local surgical treatment of cutaneous squamous cell carcinoma: deficits and controversies in the literature. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 17 (10) (2019)
Benjamin Weide, Thomas Kurt Eigentler, Chiara Catania, Paolo Antonio Ascierto, Stefano Cascinu, Jürgen Christian Becker, Axel Hauschild, Antonella Romanini, Riccardo Danielli, Reinhard Dummer, Uwe Trefzer, Giuliano Elia, Dario Neri, Claus Garbe
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients. Cancer immunology, immunotherapy : CII 68 (9) (2019)
Thomas Kurt Eigentler, Joachim Hinderer, Seema Noor, Claus Garbe, Ulrike Leiter
Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up. Journal of cancer research and clinical oncology 143 (4) (2016)

Thomas Kurt Eigentler.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas K Eigentler, T Eigentler, Thomas Eigentler)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Kurt Eigentler (Thomas K Eigentler, T Eigentler, Thomas Eigentler)